MKI67 and colorectal carcinoma: Results indicated a statistically significant increase (p < 0.001 vs. T1 patient donors) in Ki-67 expression in pathological tissues, starting from stage T2 in CRC patients (Figures 6A, B) and from stage T1 in GC patients (Figures 6D, E).